AU2003302070A1 - USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta - Google Patents

USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Info

Publication number
AU2003302070A1
AU2003302070A1 AU2003302070A AU2003302070A AU2003302070A1 AU 2003302070 A1 AU2003302070 A1 AU 2003302070A1 AU 2003302070 A AU2003302070 A AU 2003302070A AU 2003302070 A AU2003302070 A AU 2003302070A AU 2003302070 A1 AU2003302070 A1 AU 2003302070A1
Authority
AU
Australia
Prior art keywords
tgfbeta
potentiating
action
receptor antagonist
rar receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302070A
Inventor
Michel Demarchez
Andre Jomard
Alain Mauviel
Serge Michel
Valerie Pendaries
Franck VERRECCHIA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0214319A external-priority patent/FR2847167A1/en
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of AU2003302070A1 publication Critical patent/AU2003302070A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003302070A 2002-11-15 2003-11-14 USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta Abandoned AU2003302070A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0214319A FR2847167A1 (en) 2002-11-15 2002-11-15 Method for treating disorders associated with TGF-beta signal deficiency, e.g. cicatrization disorders, ulcers, cancers or graft rejection, comprises administration of retinoic acid receptor-Gamma antagonists
FR02/14319 2002-11-15
US43067102P 2002-12-04 2002-12-04
US60/430,671 2002-12-04
PCT/EP2003/014864 WO2004045595A1 (en) 2002-11-15 2003-11-14 USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFβ

Publications (1)

Publication Number Publication Date
AU2003302070A1 true AU2003302070A1 (en) 2004-06-15

Family

ID=32327936

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302070A Abandoned AU2003302070A1 (en) 2002-11-15 2003-11-14 USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta

Country Status (2)

Country Link
AU (1) AU2003302070A1 (en)
WO (1) WO2004045595A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0800517A1 (en) * 1994-12-29 1997-10-15 Allergan Acetylenes disubstituted with a 5 or 8 substituted tetrahydronaphthyl or dihydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
FR2753627B1 (en) * 1996-09-20 2003-02-21 Galderma Rech Dermatologique USE OF INHIBITORS OF RETINOIC ACID ACTIVITY TO PROMOTE HEALING
FR2755011B1 (en) * 1996-10-31 1998-11-20 Cird Galderma USE OF INHIBITORS OF RETINOIC ACID ACTIVITY TO TREAT SENSITIVE SKIN AND / OR ACUTE DAMAGE INDUCED BY U.V. RADIATION
WO1998046223A1 (en) * 1997-04-11 1998-10-22 Bristol-Myers Squibb Company Retinoid antagonists for prevention of surgical adhesions
US6313168B1 (en) * 1999-12-15 2001-11-06 Allergan Sales, Inc. Use of retinoid receptor antagonists in the treatment of cartilage and bone pathologies

Also Published As

Publication number Publication date
WO2004045595A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
EP1576112A3 (en) Cytokine receptor zcytor17 multimers
AU2003261251A1 (en) Methods of delivering therapeutic agents
IL189657A0 (en) N-phenyl-2-pyrimidine-amine derivatives
AU2003231513A1 (en) Pgd2 receptor antagonist
AU2003261723A1 (en) Cxcr4 antagonist and use thereof
AU2003254177A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
AU2003245700A1 (en) Pyrazolopyridine derivatives
AU2003256923A1 (en) Substituted benzanilides as modulators of the ccr5 receptor
AU2003275266A1 (en) Therapeutic compounds based on pyrazolopyridine derivatives
AU2003288640A1 (en) Benzamide inhibitors of the p2x7 receptor
AU2003255501A1 (en) Cxcr4 receptor antagonists
AU2003294318A1 (en) Therapeutic bioconjugates
AU2003274307A1 (en) 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
AU2003267088A1 (en) Chemokine receptor antagonists as therapeutic agents
AU2003205106A1 (en) Pace-a microspheres for delivery of antigens
AU2003279841A1 (en) Uses of human zven antagonists
AU2003260072A1 (en) Antagonists of chemokine receptors
AU2003300904A1 (en) Antagonists for human prolactin
AU2003220466A1 (en) Delayed release dosage forms
AU2003240705A1 (en) Morpholinylmethylureas ccr-3 receptor antagonists
AU2003302070A1 (en) USE OF AN RAR RECEPTOR ANTAGONIST FOR POTENTIATING THE ACTION OF TGFBeta
AU2003240922A1 (en) Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis
AU2003273803A1 (en) Use of triptans as antiviral agents
AU2003259759A1 (en) Gal3 receptor antagonists for the treatment of affective disorders
AU2003288857A1 (en) New substituted 1-phenyl-tetrahydronaphtalene derivatives and their use as inhibitors of igf-1 receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase